The pharma and biotech industries are navigating tighter capital, evolving regulations, and rising competition from breakthrough therapies in oncology, rare diseases, and obesity. Against this backdrop, the 44th Annual J.P. Morgan Healthcare Conference, taking place January 12-15, 2026, in San Francisco, will bring together leading biopharma companies, emerging innovators, investors, and healthcare technology developers. The event will highlight corporate updates on commercial performance, clinical progress, regulatory milestones, and strategic priorities.
Below are key updates from a few companies scheduled to present at the conference.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.